Review article · 30 Oct 2023
Conference abstractPublished 13 Jun 2016
Breast cancer heterogeneity
Central Hospital Falun, Sweden
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Breast cancer is a heterogeneous disease with individual cases varying in morphology, clinical and radiological manifestations, prognosis, and therapy response. Heterogeneity is frequently seen within the same tumor and in general refers to co-existence of more than one tumor cell subpopulations with regard to histological tumor type and grade, protein expression or genetic characteristics. Foci deviating from one another with regard to their estrogen and progesterone receptor status are seen in approximately 10% of multifocal carcinomas similar to differences in HER2 over-expression. Variations in Ki67 proliferation index are also frequent. Heterogeneity may potentially lead to discordant results dependent on which part of the tumor is embedded and examined. This problem is even more obvious in core biopsy âÂ?Â? surgical specimen correlation and in relation of primary tumors and metastatic foci. More importantly, the different subpopulations may influence the assessment of the tumorsâÂ?Â? molecular phenotype and potentially may lead to under-treatment of the patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 19 Sep 2016
Glucocorticoid signaling is a molecular mechanism to define the heterogeneity of different subtypes of breast cancer
Conference abstract · 3 Aug 2015
Circulating Tumour cells and Breast Cancer Heterogeneity
Conference abstract · 1 Jul 2016
Understanding the heterogeneity of breast cancer: Referencing the normal breast luminal epithelium
Conference abstract · 2 Nov 2015
Heterogeneity of Triple-negative breast cancer across race and ethnicities, Indian women at higher risk: Should we be heading towards personalized medicine?
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Tibor Tot”

